Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1993 Oct 15;90(20):9499–9503. doi: 10.1073/pnas.90.20.9499

Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis.

B A Mock 1, M M Krall 1, J K Dosik 1
PMCID: PMC47596  PMID: 8105477

Abstract

Plasmacytomas (PCTs) were induced in 47% of BALB/cAnPt mice by the intraperitoneal injection of pristane, in 2% of (BALB/c x DBA/2N)F1, and in 11% of 773 BALB/cAnPt x (BALB/cAnPt x DBA/2N)F1 N2 backcross mice. This result indicates a multigenic mode of inheritance for PCT susceptibility. To locate genes controlling this complex genetic trait, tumor susceptibility in backcross progeny generated from BALB/c and DBA/2N (resistant) mice was correlated with alleles of 83 marker loci. The genotypes of the PCT-susceptible progeny displayed an excess homozygosity for BALB/c alleles within a 32-centimorgan stretch of mouse chromosome 4 (> 95% probability of linkage) with minimal recombination (12%) near Gt10. Another susceptibility gene on mouse chromosome 1 may be linked to Fcgr2 (90% probability of linkage); there were excess heterozygotes for Fcgr2 among the susceptible progeny and excess homozygotes among the resistant progeny. Regions of mouse chromosomes 4 and 1 that are correlated with PCT susceptibility share extensive linkage homology with regions of human chromosome 1 that have been associated with cytogenetic abnormalities in multiple myeloma and lymphoid, breast, and endocrine tumors.

Full text

PDF
9500

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott C. M., Blank R., Eppig J. T., Friedman J. M., Huppi K. E., Jackson I., Mock B. A., Stoye J., Wiseman R. Mouse chromosome 4. Mamm Genome. 1992;3(Spec No):S55–S64. doi: 10.1007/BF00648422. [DOI] [PubMed] [Google Scholar]
  2. Anderson P. N., Potter M. Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature. 1969 Jun 7;222(5197):994–995. doi: 10.1038/222994a0. [DOI] [PubMed] [Google Scholar]
  3. Atkin N. B. Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet. 1986 Apr 15;21(4):279–285. doi: 10.1016/0165-4608(86)90206-2. [DOI] [PubMed] [Google Scholar]
  4. Bahary N., McGraw D. E., Shilling R., Friedman J. M. Microdissection and microcloning of mid-chromosome 4: genetic mapping of 41 microdissection clones. Genomics. 1993 Apr;16(1):113–122. doi: 10.1006/geno.1993.1148. [DOI] [PubMed] [Google Scholar]
  5. Begley C. G., Visvader J., Green A. R., Aplan P. D., Metcalf D., Kirsch I. R., Gough N. M. Molecular cloning and chromosomal localization of the murine homolog of the human helix-loop-helix gene SCL. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):869–873. doi: 10.1073/pnas.88.3.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bothwell A. L., Paskind M., Schwartz R. C., Sonenshein G. E., Gefter M. L., Baltimore D. Dual expression of lambda genes in the MOPC-315 plasmacytoma. Nature. 1981 Mar 5;290(5801):65–67. doi: 10.1038/290065a0. [DOI] [PubMed] [Google Scholar]
  7. Callahan R., Gallahan D., Kozak C. Two genetically transmitted BALB/c mouse mammary tumor virus genomes located on chromosomes 12 and 16. J Virol. 1984 Mar;49(3):1005–1008. doi: 10.1128/jvi.49.3.1005-1008.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dietrich W., Katz H., Lincoln S. E., Shin H. S., Friedman J., Dracopoli N. C., Lander E. S. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics. 1992 Jun;131(2):423–447. doi: 10.1093/genetics/131.2.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ferti A., Panani A., Arapakis G., Raptis S. Cytogenetic study in multiple myeloma. Cancer Genet Cytogenet. 1984 Jul;12(3):247–253. doi: 10.1016/0165-4608(84)90036-0. [DOI] [PubMed] [Google Scholar]
  10. Field L. J., McGowan R. A., Dickinson D. P., Gross K. W. Tissue and gene specificity of mouse renin expression. Hypertension. 1984 Jul-Aug;6(4):597–603. doi: 10.1161/01.hyp.6.4.597. [DOI] [PubMed] [Google Scholar]
  11. Fukuhara S., Nasu K., Kita K., Ueshima Y., Oguma S., Yamabe H., Nishigori M., Uchino H. Cytogenetic approaches to the clarification of pathogenesis in lymphoid malignancies: clinicopathologic characterization of 14q+ marker-positive non-T-cell malignancies. Jpn J Clin Oncol. 1983 Sep;13(3):461–475. [PubMed] [Google Scholar]
  12. Gahrton G., Zech L., Nillsson K., Lönnqvist B., Carlström A. 2 translocations, t(11;14) and t(1;6), in a patient with plasma cell leukaemia and 2 populations of plasma cells. Scand J Haematol. 1980 Jan;24(1):42–46. doi: 10.1111/j.1600-0609.1980.tb01315.x. [DOI] [PubMed] [Google Scholar]
  13. Geiser A. G., Stanbridge E. J. A review of the evidence for tumor suppressor genes. Crit Rev Oncog. 1989;1(3):261–276. [PubMed] [Google Scholar]
  14. Goodwin R. G., Anderson D., Jerzy R., Davis T., Brannan C. I., Copeland N. G., Jenkins N. A., Smith C. A. Molecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor. Mol Cell Biol. 1991 Jun;11(6):3020–3026. doi: 10.1128/mcb.11.6.3020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Guénet J. L., Watson M., Seldin M. F. Mouse chromosome 19. Mamm Genome. 1992;3(Spec No):S266–S273. [PubMed] [Google Scholar]
  16. Haber D. A., Housman D. E. Rate-limiting steps: the genetics of pediatric cancers. Cell. 1991 Jan 11;64(1):5–8. doi: 10.1016/0092-8674(91)90200-i. [DOI] [PubMed] [Google Scholar]
  17. Hanley-Hyde J., Mushinski J. F., Sadofsky M., Huppi K., Krall M., Kozak C. A., Mock B. Expression of murine cyclin B1 mRNAs and genetic mapping of related genomic sequences. Genomics. 1992 Aug;13(4):1018–1030. doi: 10.1016/0888-7543(92)90015-k. [DOI] [PubMed] [Google Scholar]
  18. Hilbert P., Lindpaintner K., Beckmann J. S., Serikawa T., Soubrier F., Dubay C., Cartwright P., De Gouyon B., Julier C., Takahasi S. Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature. 1991 Oct 10;353(6344):521–529. doi: 10.1038/353521a0. [DOI] [PubMed] [Google Scholar]
  19. Huang H. J., Jones N. H., Strominger J. L., Herzenberg L. A. Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1 (CD5). Proc Natl Acad Sci U S A. 1987 Jan;84(1):204–208. doi: 10.1073/pnas.84.1.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Huppi K., Bhatia K., Siwarski D., Klinman D., Cherney B., Smulson M. Sequence and organization of the mouse poly (ADP-ribose) polymerase gene. Nucleic Acids Res. 1989 May 11;17(9):3387–3401. doi: 10.1093/nar/17.9.3387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Huppi K., Mock B. A., Schricker P., D'Hoostelaere L. A., Potter M. Organization of the distal end of mouse chromosome 4. Curr Top Microbiol Immunol. 1988;137:276–288. doi: 10.1007/978-3-642-50059-6_42. [DOI] [PubMed] [Google Scholar]
  22. Jacob H. J., Lindpaintner K., Lincoln S. E., Kusumi K., Bunker R. K., Mao Y. P., Ganten D., Dzau V. J., Lander E. S. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell. 1991 Oct 4;67(1):213–224. doi: 10.1016/0092-8674(91)90584-l. [DOI] [PubMed] [Google Scholar]
  23. Jonasson J., Povey S., Harris H. The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J Cell Sci. 1977 Apr;24:217–254. doi: 10.1242/jcs.24.1.217. [DOI] [PubMed] [Google Scholar]
  24. Kelley K. A., Kozak C. A., Dandoy F., Sor F., Skup D., Windass J. D., DeMaeyer-Guignard J., Pitha P. M., DeMaeyer E. Mapping of murine interferon-alpha genes to chromosome 4. Gene. 1983 Dec;26(2-3):181–188. doi: 10.1016/0378-1119(83)90188-9. [DOI] [PubMed] [Google Scholar]
  25. Kirsch I. R., Ravetch J. V., Kwan S. P., Max E. E., Ney R. L., Leder P. Multiple immunoglobulin switch region homologies outside the heavy chain constant region locus. Nature. 1981 Oct 15;293(5833):585–587. doi: 10.1038/293585a0. [DOI] [PubMed] [Google Scholar]
  26. Kleene K. C., Distel R. J., Hecht N. B. cDNA clones encoding cytoplasmic poly(A)+ RNAs which first appear at detectable levels in haploid phases of spermatogenesis in the mouse. Dev Biol. 1983 Aug;98(2):455–464. doi: 10.1016/0012-1606(83)90375-5. [DOI] [PubMed] [Google Scholar]
  27. Krall M., Ruff N., Zimmerman K., Aggarwal A., Dosik J., Reeves R., Mock B. A. Isolation and mapping of four new DNA markers from mouse chromosome 4. Mamm Genome. 1992;3(11):653–655. doi: 10.1007/BF00352484. [DOI] [PubMed] [Google Scholar]
  28. Lang R. B., Stanton L. W., Marcu K. B. On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed. Nucleic Acids Res. 1982 Jan 22;10(2):611–630. doi: 10.1093/nar/10.2.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lewis J. P., MacKenzie M. R. Non-random chromosomal aberrations associated with multiple myeloma. Hematol Oncol. 1984 Oct-Dec;2(4):307–317. doi: 10.1002/hon.2900020402. [DOI] [PubMed] [Google Scholar]
  30. Liang W., Hopper J. E., Rowley J. D. Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders. Cancer. 1979 Aug;44(2):630–644. doi: 10.1002/1097-0142(197908)44:2<630::aid-cncr2820440233>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  31. MERWIN R. M., ALGIRE G. H. Induction of plasma-cell neoplasms and fibrosarcomas in BALB/c mice carrying diffusion chambers. Proc Soc Exp Biol Med. 1959 Jul;101(3):437–439. doi: 10.3181/00379727-101-24970. [DOI] [PubMed] [Google Scholar]
  32. Mock B. A., D'Hoostelaere L. A., Matthai R., Huppi K. A mouse homeo box gene, Hox-1.5, and the morphological locus, Hd, map to within 1 cM on chromosome 6. Genetics. 1987 Aug;116(4):607–612. doi: 10.1093/genetics/116.4.607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mock B., Krall M., Blackwell J., O'Brien A., Schurr E., Gros P., Skamene E., Potter M. A genetic map of mouse chromosome 1 near the Lsh-Ity-Bcg disease resistance locus. Genomics. 1990 May;7(1):57–64. doi: 10.1016/0888-7543(90)90518-y. [DOI] [PubMed] [Google Scholar]
  34. Morris S. W., Nelson N., Valentine M. B., Shapiro D. N., Look A. T., Kozlosky C. J., Beckmann M. P., Cerretti D. P. Assignment of the genes encoding human interleukin-8 receptor types 1 and 2 and an interleukin-8 receptor pseudogene to chromosome 2q35. Genomics. 1992 Nov;14(3):685–691. doi: 10.1016/s0888-7543(05)80169-7. [DOI] [PubMed] [Google Scholar]
  35. Neumann P. E., Collins R. L. Genetic dissection of susceptibility to audiogenic seizures in inbred mice. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5408–5412. doi: 10.1073/pnas.88.12.5408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Neumann P. E. Inference in linkage analysis of multifactorial traits using recombinant inbred strains of mice. Behav Genet. 1992 Nov;22(6):665–676. doi: 10.1007/BF01066637. [DOI] [PubMed] [Google Scholar]
  37. Nimer S. D., Golde D. W. The 5q- abnormality. Blood. 1987 Dec;70(6):1705–1712. [PubMed] [Google Scholar]
  38. Offit K., Wong G., Filippa D. A., Tao Y., Chaganti R. S. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations. Blood. 1991 Apr 1;77(7):1508–1515. [PubMed] [Google Scholar]
  39. POTTER M., BOYCE C. R. Induction of plasma-cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants. Nature. 1962 Mar 17;193:1086–1087. doi: 10.1038/1931086a0. [DOI] [PubMed] [Google Scholar]
  40. Potter M., Hartley J. W., Wax J. S., Gallahan D. Effect of MuLV-related genes on plasmacytomagenesis in BALB/c mice. J Exp Med. 1984 Aug 1;160(2):435–440. doi: 10.1084/jem.160.2.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Potter M., Pumphrey J. G., Bailey D. W. Genetics of susceptibility to plasmacytoma induction. I. BALB/cAnN (C), C57BL/6N (B6), C57BL/Ka (BK), (C times B6)F1, (C times BK)F1, and C times B recombinant-inbred strains. J Natl Cancer Inst. 1975 Jun;54(6):1413–1417. doi: 10.1093/jnci/54.6.1413. [DOI] [PubMed] [Google Scholar]
  42. Potter M., Wax J. S. Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J Immunol. 1981 Oct;127(4):1591–1595. [PubMed] [Google Scholar]
  43. Potter M., Wax J. S. Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens. J Natl Cancer Inst. 1983 Aug;71(2):391–395. [PubMed] [Google Scholar]
  44. Potter M., Wiener F. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis. 1992 Oct;13(10):1681–1697. doi: 10.1093/carcin/13.10.1681. [DOI] [PubMed] [Google Scholar]
  45. Ravetch J. V., Luster A. D., Weinshank R., Kochan J., Pavlovec A., Portnoy D. A., Hulmes J., Pan Y. C., Unkeless J. C. Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors. Science. 1986 Nov 7;234(4777):718–725. doi: 10.1126/science.2946078. [DOI] [PubMed] [Google Scholar]
  46. Rise M. L., Frankel W. N., Coffin J. M., Seyfried T. N. Genes for epilepsy mapped in the mouse. Science. 1991 Aug 9;253(5020):669–673. doi: 10.1126/science.1871601. [DOI] [PubMed] [Google Scholar]
  47. Rousseau-Merck M. F., Simon-Chazottes D., Arpin M., Pringault E., Louvard D., Guénet J. L., Berger R. Localization of the villin gene on human chromosome 2q35-q36 and on mouse chromosome 1. Hum Genet. 1988 Feb;78(2):130–133. doi: 10.1007/BF00278181. [DOI] [PubMed] [Google Scholar]
  48. Seldin M. F. Mouse chromosome 1. Mamm Genome. 1992;3(Spec No):S1–19. [PubMed] [Google Scholar]
  49. Skarnes W. C., Auerbach B. A., Joyner A. L. A gene trap approach in mouse embryonic stem cells: the lacZ reported is activated by splicing, reflects endogenous gene expression, and is mutagenic in mice. Genes Dev. 1992 Jun;6(6):903–918. doi: 10.1101/gad.6.6.903. [DOI] [PubMed] [Google Scholar]
  50. Stanton L. W., Watt R., Marcu K. B. Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas. Nature. 1983 Jun 2;303(5916):401–406. doi: 10.1038/303401a0. [DOI] [PubMed] [Google Scholar]
  51. Stoler A., Bouck N. Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation. Proc Natl Acad Sci U S A. 1985 Jan;82(2):570–574. doi: 10.1073/pnas.82.2.570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Todd J. A., Aitman T. J., Cornall R. J., Ghosh S., Hall J. R., Hearne C. M., Knight A. M., Love J. M., McAleer M. A., Prins J. B. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature. 1991 Jun 13;351(6327):542–547. doi: 10.1038/351542a0. [DOI] [PubMed] [Google Scholar]
  53. Van Ness B. G., Coleclough C., Perry R. P., Weigert M. DNA between variable and joining gene segments of immunoglobulin kappa light chain is frequently retained in cells that rearrange the kappa locus. Proc Natl Acad Sci U S A. 1982 Jan;79(2):262–266. doi: 10.1073/pnas.79.2.262. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES